Organigram: Consensus Analyst Estimates For Q2 2021
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April 13th before the market open.
Read more
Organigram Holdings
Raymond James Reiterates $6 Price Target On Organigram Holdings
On April 6th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they acquired cannabis 2.0 operator The Edibles & Infusions
Read more
Organigram Quietly Announces $58.5 Million BMO Debt Repayment
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) on Thursday quietly announced that they had repaid outstanding facilities with the Bank of
Read more
Organigram: Analysts Upgrade Targets Following BAT Investment
On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221 million strategic investment from British
Read more
Organigram Holdings Sees British American Tobacco Take 19.9% Stake In Firm
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) has seen a strategic investment from that of BAT (NYSE: BTI), whom is more
Read more
Organigram: Mixed Commentary From Analysts Following Q1 2021 Results
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) yesterday morning reported its first-quarter 2021 financial results for the period ended November 30,
Read more
Organigram Posts Revenues Of $19.3 Million, Loss Of $34.3 Million In Q1 2021
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) this morning reported its first quarter 2021 financial results for the period ended November
Read more
Organigram: Canaccord Lowers Price Target To $2.50
Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced net revenues of $20.4 million,
Read more
Organigram Posts Q4 Revenues of $20.4 Million, Loss Of $38.6 Million
Organigram Holdings (TSX: OGI) (NASDAQ: OGI) this morning reported its fourth quarter financials, with net revenues of $20.4 million and
Read more
Organigram: Raymond James Drops Price To $3.00 Ahead Of Earnings
On Friday, Raymond James reiterated Organigram Holdings (TSX: OGI) (NASDAQ: OGI)‘ market perform rating while downgrading their 12-month price target
Read more